LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 1311 | 5397 | 5010 | 1.0771 | 1.0783 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1311 | 4974 | 5128 | 0.9699 | 0.9692 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1311 | 4866 | 5100 | 0.9541 | 0.9526 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1311 | 5042 | 5010 | 1.0062 | 1.0064 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 1311 | 4544 | 5128 | 0.8861 | 0.8807 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 1311 | 4521 | 5100 | 0.8865 | 0.8807 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 1311 | 4507 | 5010 | 0.8995 | 0.8933 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1311 | 2828 | 5128 | 0.5514 | 0.4778 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1311 | 2722 | 5100 | 0.5337 | 0.4516 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1311 | 2739 | 5010 | 0.5466 | 0.4634 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 1311 | 1730 | 5128 | 0.3373 | 0.1511 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 1311 | 1552 | 5100 | 0.3043 | 0.0897 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 1311 | 1539 | 5010 | 0.3071 | 0.0862 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 1 | H01 | 72 | hr | 1311 | 727 | 5128 | 0.1418 | -0.2592 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 2 | H01 | 72 | hr | 1311 | 735 | 5100 | 0.1441 | -0.2560 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 3 | H01 | 72 | hr | 1311 | 743 | 5010 | 0.1483 | -0.2547 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1311 | 5097 | 5128 | 0.9939 | 0.9938 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 1311 | 5190 | 5100 | 1.0176 | 1.0179 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 1311 | 5254 | 5010 | 1.0485 | 1.0496 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 1311 | 4663 | 5128 | 0.9093 | 0.9056 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 1311 | 4947 | 5100 | 0.9700 | 0.9691 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 1311 | 4866 | 5010 | 0.9711 | 0.9699 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 1311 | 4652 | 5128 | 0.9071 | 0.9033 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 1311 | 4988 | 5100 | 0.9780 | 0.9775 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 3 | G10 | 72 | hr | 1311 | 4909 | 5010 | 0.9797 | 0.9789 |